Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis
PaperCitations, authors & open-access status
A Phase 2, Double-Blind, Placebo-Controlled, Randomized Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 134 citations, 2017 year and gold oa status.
134
Citations
2017
Year
gold
OA Status